Categorisation of psychosocial factors in pharmacotherapeutic follow-up in the A.S.E. model, in pharmaceutical office pharmacists;Categorizaciíon de los factores psicosociales del seguimiento farmacoterapéutico en el modelo A.S.E., en farmacéuticos de oficina de farmacia

Pharmaceutical Care Espana

Volumn 5, Issue 5, 2003, Pages 216-225

  Zardain Tamargo, Emma ^a,b   López González, Ma Luisa ^a  

^a UNIVERSIDAD DE OVIEDO   (Spain)

^b NONE   (Spain)

Author keywords

Community pharmacy services; Knowledge, attitudes, practice; Motivation; Pharmaceutical services; Pharmacists; Questionnaires

Indexed keywords

ARTICLE; ATTITUDE; AUTHORITY; BEHAVIOR; COMMUNITY; CULTURAL FACTOR; FOLLOW UP; HEALTH CARE DELIVERY; HEALTH CARE SYSTEM; PHARMACEUTICAL CARE; PHARMACIST; PHARMACY; PROFESSIONAL PRACTICE; QUALITATIVE ANALYSIS; QUESTIONNAIRE; SELF CONCEPT; SOCIAL ASPECT; SOCIAL PSYCHOLOGY; THEORETICAL MODEL;

EID: 0242521679     PISSN: 11396202     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (33)

1. Dirección General de Farmacia y Productos Sanitarios. Consenso sobre Atención Farmacéutica. Madrid: Ministerio de Sanidad y Consumo; 2001.
2. De Vries H, Dijkstra M, Kuhlman. Self-efficacy: third factor besides attitude and subjective norm as a predictor of behavioral intentions. Health Educ Res 1988;3:273-282.
3. De Vries H, Backbier E, Kok G, Dijkstra M. The impact of social influences in the context of attitude, self-efficacy, intention and previous behaviour as predictors of smoking onset. J Appl Soc Psychol 1995;25:237-57.
4. Fishbein M, Ajzen I. Belief attitude, intention and behavior: an introduction to theory and research. Reading, MA: Addison-Wesley, 1975.
5. Ajzen I, Fishbein M. Understanding attitudes and predicting social behavior. Englewood Cliffs: Prentice-Hall; 1980.
6. Prochaska JO, DiClemente CC. The transtheoretical approach: crossing traditional boundaries of therapy. Homewood, IL: Dow Jones-Irwin; 1984.
7. Plaza L. El nuevo reto de la Atención Farmacéutica: la búsqueda del acuerdo entre profesionales.[tesis doctoral]. Sevilla: Universidad de Sevilla; 2001.
8. Krueger RA. El grupo de discusión. Guío práctica para la investigación aplicada. Madrid: Pirámide; 1991.
9. Hassell K, Hibbert D. The use of focus groups in pharmacy research: processes and practicalities. J Soc Admin Pharm 1996;13(4):169-77.
10. Pope C, Mays N. Qualitative research in health care. BMJ books. En: http://www.bmpg.com/qrhc/contents.html. 15-05-02
11. Burnard P. A method of analysing interview transcripts in qualitative research. Nurse Educ Today 1991;11(6):461-6.
12. Berger BA, Grimley D. Pharmacists' readiness for rendering pharmaceutical care. J Am Pharm Assoc 1997; NS37:535-42.
13. Latif DA. Situational factors as determinants of community pharmacists' clinical decision making behavior. J Am Pharm Assoc 1998;38(4):446-50.
14. Fronic D, Pathak DS. Situational factors as predictors of pharmaceutical care in a community setting: an application of the adaptative decision-making model. Pharm Pract Manage Q 1999;18(4):19-28.
15. Odedina FK, Segal R, Hepler CD. Providing pharmaceutical care in community practice: differences between providers and non-providers of pharmaceutical care. J Soc Adm Pharm 1995;12(4):170-180.
16. Odedina FT, Hepler CD, Segal R, Miller D. The pharmacists' implementation of pharmaceutical care (PIPC) model. [abstract]. Pharm Res 1997;14(2):135-44.
17. Nimmo CM, Holland RW. Transitions in pharmacy practice, part 2: who does what and why. Am J Health-Syst Pharm 1999;56:1981-7.
18. Holland RW, Nimmo CM. Transitions in pharmacy practice, part 3: effecting change- the three-ring circus. Am J Health-Syst Pharm 1999;56:2235-41.
19. Nimmo CM, Holland RW. Transitions in pharmacy practice, part 4: can a leopard change its spots?. Am J Health-Syst Pharm 1999;56:2458-62.
20. Nimmo CM, Holland RW. Transitions in pharmacy practice, part 5: walking the tightrope of change. Am J Health-Syst Pharm 2000;57:64-72.
21. Holland RW, Nimmo CM. Transitions in pharmacy practice, part I: beyond pharmaceutical care. Am J Health-Syst Pharm 1999;56(17):1758-64.
22. Penna RP. Pharmaceutical car: Pharmacy's mission for the 1990s. Am J Hosp Pharm 1990;47:543-9.
23. Miller MJ, Ortmeier BG. Factors influencing the delivery of pharmacy services. Am Pharm 1995;NS35(1):39-45.
24. Pharmacy in the 21st century. The third strategic planning conference for pharmacy practice. Appendix A. Workshop II. Identifying barriers and potential strategies. Am Pharm 1995;NS35 supl 1:43-8.
25. McDonough RP, Rovers JP, Currie JD, Hagel H, Vallandingham J, Sobotka J. Obstacles to the implementation of pharmaceutical care in the community setting. J Am Pharm Assoc 1998;38:87-95.
26. Bell HM, McElnay JC, Hughes CM, Woods A. A qualitative investigation of the attitudes and opinions of community pharmacists to pharmaceutical care. J Soc Adm Pharm 1998;15(4):284-294.
27. Krska J, Veitch GBA. Perceived factors influencing the development of primary care-based pharmaceutical care in Scotland. Int J Pharm Pract 2001;9:243-52.
28. Krska J, Veitch GBA. Providing pharmaceutical care - the views of Scottish pharmacists, Pharm J 2001;267:549-55.
29. Cordina M, McElnay JC, Hughes CM. The importance that community pharmacists in Malta place on the introduction of pharmaceutical care. Pharm World Sci 1999;21(2):69-73.
30. Farris KB, Schopflocher DP. Between intention end behavior: an application of community pharmacists' assessment of pharmaceutical care. Soc Sci Med 1999;49:55-66.
31. Van Mil JWF, De Boer WO, Tromp TFJ. European barriers to the implementation of pharmaceutical care. Int J Pharm Pract 2001;9:163-8.
32. FIP Congress, Nice 3 september 2002. Community Pharmacy Section. Managing Change. Tromp D. Holland RW, Nimmo CM, Mesnil M, Peura S, Henry J.
33. van Es SM, Kaptein AA, Bezemer PD, Nagelkerke AF, Colland VT, Bouter LM. Predicting adherence to prophylactic medication in adolescents with asthma: an application of the ASE-model. Patient Educ Couns 2002;47(2):165-71.